Dissecting Pathway Disturbances Using Network Topology and Multi-platform Genomics Data
- 72 Downloads
Complex diseases such as cancers usually result from accumulated disturbance of pathways instead of the disruptions of one or a few major genes. As opposed to single-platform analyses, it is likely that integrating diverse molecular regulatory elements and their interactions can lead to more insights on pathway-level disturbances of biological systems and their potential consequences in disease development and progression. To explore the benefit of pathway-based analysis, we focus on multi-platform genomics, epigenomics, and transcriptomics (-omics, for short) from 11 cancer types collected by The Cancer Genome Atlas project. Specifically, we use a well-studied oncogenic pathway, the BRAF pathway, to investigate the relevant copy number variants (CNVs), methylations, and gene expressions, and quantify their effects on discovering tumor-specific aberrations across multiple tumor lineages. We also perform simulation studies to further investigate the effects of network topology and multiple omics on dissecting pathway disturbances. Our analysis shows that adding molecular regulatory elements such as CNVs and/or methylations to the baseline mRNA molecules can improve our power of discovering tumorous aberrances. Also, incorporating CNVs with the baseline mRNA molecules can be more beneficial than incorporating methylations. Moreover, employing regulatory topologies can improve the discoveries of tumorous aberrances. Finally, our analysis reveals similarities and differences among diverse cancer types based on disturbance of the BRAF pathway.
KeywordsData integration Multi-platform genomics Network topology Pathway analysis
We thank all the members of the Statistical and Applied Mathematical Sciences Institute (SAMSI) Data Integration: TCGA Working Group as part of the SAMSI Beyond Bioinformatics Program. We are grateful for the support of Dr. Sujit Ghosh at SAMSI. This research was partially supported by the InCHIP Faculty Affiliate Seed Grant at UConn (to YZ), Faculty Research Excellence Program Award at UConn (to YZ), the CICATS PreK Career Development Award at UConn (to YZ), and the Research Starter Grant in Informatics from PhRMA Foundation (to ZO). VB was partially supported by the following grants: NIH Grants R01 CA160736, R01CA194391, P30 CA016672, and NSF DMS 1463233 and the National Institutes of Health (NIH) Grants R01 GM59507 (to HZ), P01 CA154295 (to HZ), and P30 CA016359 (to HZ).
- 5.Liu L, Ruan J (2013) Network-based pathway enrichment analysis. In: 2013 IEEE international conference on bioinformatics and biomedicine (BIBM). IEEE, p 218–221Google Scholar
- 8.Maciejewski H (2013) Gene set analysis methods: statistical models and methodological differences. Brief Bioinform. doi: 10.1093/bib/bbt002
- 10.Shojaie A, Michailidis G (2010) Network enrichment analysis in complex experiments. Stat Appl Genet Mol Biol. doi: 10.2202/1544-6115.1483
- 11.Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550CrossRefGoogle Scholar
- 13.Tomczak K, Czerwińska P, Wiznerowicz M (2015) The cancer genome atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol 19(1A):A68Google Scholar